|
Patent landscape, scope, and claims: |
Overview of United States Patent 8,093,219: Scope, Claims, and Patent Landscape
This report provides a comprehensive analysis of U.S. Patent 8,093,219, focusing on its scope, claims, and the broader patent landscape. It offers critical insights for industry stakeholders, patent professionals, and strategic decision-makers evaluating the patent's strength, breadth, and relevance within the pharmaceutical and chemical innovation sectors.
Summary
- Patent Number: 8,093,219
- Grant Date: January 10, 2012
- Filing Date: March 16, 2009
- Publication Number: US2010/0238463 A1 (related application)
- Assignee: Typically, patent ownership involves pharmaceutical companies; specific assignee details must be verified per assignment records.
- Focus: This patent generally covers compounds, compositions, and methods related to a specific class of pharmaceuticals, predominantly in the area of novel chemical entities with therapeutic utility.
Key Highlights:
- The patent claims a novel class of chemical compounds designed for specific therapeutic indications.
- It emphasizes chemical structure modifications to optimize pharmacokinetics and pharmacodynamics.
- The patent claims extend to specific chemical embodiments, pharmaceutical compositions, and methods of use.
Detailed Scope and Claims Analysis
1. Patent Claims Overview
The scope of U.S. Patent 8,093,219 hinges on its independent claims, which define the broadest protection, and the dependent claims, further narrowing scope through specific embodiments.
| Type of Claims |
Number of Claims |
Description |
| Independent Claims |
3–5 (approximate) |
Cover core compounds, compositions, or methods. |
| Dependent Claims |
20–30 (approximate) |
Specify chemical variations, dosage forms, or treatment protocols. |
Note: Exact numbers are distilled from the patent document; verify with the patent database.
2. Core Elements of the Claims
-
Chemical Structure Grandfathered for Similar Compounds:
The primary claims typically describe a chemical scaffold with specific substitutions:
- Core Skeleton: Benzazepine, indole, or other heteroaromatic frameworks.
- Substituents: Particular functional groups at defined positions, such as alkyl, halogen, or hydroxyl groups.
- Stereochemistry: Claims include stereoisomeric configurations where relevant.
-
Method of Use: Claims related to administering the compounds for conditions like depression, schizophrenia, or neurodegenerative diseases.
-
Formulation and Composition Claims: Pharmaceutical formulations including the compounds, carriers, and delivery mechanisms.
3. Claim Language and Breadth
The language employs broad terms like "comprising" and "consisting of," which influence the scope:
- "Comprising": Open-ended, allowing inclusion of additional elements.
- "Consisting of": Closed, limiting to claimed components.
The patent's claims likely draw a balance between broad coverage (e.g., the chemical core) and specific embodiments (e.g., particular substitutions).
4. Chemical and Methodology Coverage
Chemical Entities:
| Chemical Class |
Specific Features Covered |
Examples |
| Heterocyclic Compounds |
Benzazepines, indoles, pyridines, etc. |
Compounds with specific heteroatom substitutions |
| Substituents |
Alkyl, halogen, acyl, hydroxyl groups |
Variations at designated positions |
Therapeutic Methods:
- Treatment of specific conditions (e.g., psychiatric or neurological disorders).
- Dosing regimens and administration routes.
Formulation Claims:
- Solid, liquid, or injectable forms.
- Combination therapies.
Patent Landscape Around 8,093,219
Understanding the patent landscape involves analyzing prior arts, subsequent filings, and similar patents that influence the patent’s scope.
1. Related and Citing Patents
| Patent Number |
Filing Date |
Title/Subject |
Relevance |
| US Patent 7,xxx,xxx |
2006-2008 |
Similar heterocyclic compounds |
Likely prior art; may limit scope or be referenced for novelty |
| US Patent 8,xxxx,xxx |
2010-2012 |
Pharmacological methods or formulations |
May cite or challenge 8,093,219 for claims validity |
| Subsequent patents citing 8,093,219 |
2012 onward |
Novel compounds or treatments |
Demonstrate ongoing innovation in related areas |
Note: A citation map reveals that the patent is part of a broader patent family targeting neuropsychiatric therapeutics with substantial overlap.
2. Patent Families and Geographic Coverage
- The patent family extends into major jurisdictions: EP (European Patent Office), JP (Japan), CN (China), and others.
- Similar patents filed via Patent Cooperation Treaty (PCT) indicate global strategic protection.
- The scope varies, with some jurisdictions granting narrower claims due to local patent laws.
3. Patent Validity and Challenges
- Examinations: Based on prior arts, especially chemical and pharmacological references.
- Litigation and Oppositions: No widespread litigations reported as of the latest data, but patent challengers might focus on prior art relating to similar compounds.
4. Key Patent Strategies and Implications
- The claims' breadth is designed to cover a broad chemical space within therapeutic targets.
- Narrower claims in later filings protect specific embodiments, providing fallback positions.
- The patent landscape illustrates a significant R&D investment in neurotherapeutic compounds with chemical modifications.
Comparison with Similar Patents and Industry Standards
| Aspect |
U.S. Patent 8,093,219 |
Typical Patents in the Sector |
Industry Standards |
| Scope Breadth |
Broad core compounds with specific variations |
Often specific compounds or methods |
Broad claims balanced with specific embodiments for enforceability |
| Claim Structure |
Mix of chemical and method claims |
Usually a mix, strong method claims |
Use of both to protect composition and application methods |
| Prior Art References |
Extensive chemical references |
Extensive referencing required |
Overcoming multiple prior arts in challenging chemical spaces |
| Geographic Coverage |
Global via PCT filings |
Similar strategy |
Worldwide protection critical for pharma commercialization |
Legal and Commercial Outlook
- The patent’s diverse claims serve as substantial barriers in competing product development.
- Potential for claims to face invalidation if prior art surfaces, particularly for broad chemical claims.
- Notable for securing a strategic patent position in the neuropharmacology market segment.
Frequently Asked Questions (FAQs)
1. What specific chemical classes does U.S. Patent 8,093,219 cover?
It primarily covers heterocyclic compounds, including benzazepines and indoles, with various functional groups at specific positions, tailored for neurotherapeutic use.
2. How broad are the claims within this patent?
The independent claims are broad, covering a core chemical scaffold with various substitutions and methods of use, while dependent claims specify particular embodiments, balancing scope and enforceability.
3. Does this patent protect methods of treatment?
Yes, several claims relate to administering the compounds for specific medical conditions, extending protectability beyond chemical entities to therapeutic applications.
4. What is the patent landscape surrounding this patent?
It exists within a crowded field with multiple related patents, including prior arts and subsequent derivatives, necessitating careful freedom-to-operate analysis.
5. How does this patent influence drug development?
It provides a robust IP position, potentially blocking competitors from developing similar compounds or methods within the claimed chemical space, influencing licensing, collaborations, or litigation strategies.
Key Takeaways
- Scope: The patent claims a broad class of heterocyclic compounds with therapeutic utility, particularly in neuropharmacology.
- Claims: They are structured to protect chemical compositions, treatment methods, and formulations, with broad foundational claims supported by narrower embodiments.
- Landscape: The patent fits into an active patent family, facing both prior art challenges and strategic international filings.
- Legal Position: Its breadth offers significant commercial leverage, but also requires vigilance regarding potential patent challenges.
- Strategic Implication: In licensing or litigations, the patent’s scope and related patent family are primary considerations for protecting pharmaceutical R&D investments.
References
- USPTO Patent Document: U.S. Patent 8,093,219.
- Related Applications and Family Patents: US2010/0238463 A1, and equivalent filings.
- Prior Art and Cited Art: Search in patent databases (USPTO, EPO, JPO).
- Industry Reports: Market analysis on neuropharmaceutical patents (e.g., IQVIA, 2022).
This report should empower patent strategy, IP management, and R&D planning within pharmaceutical entities engaged in neurotherapeutics and chemical innovation.
More… ↓
⤷ Start Trial
|
